PTB testing method for finger ring dosemeters has proven its effectiveness

June 20, 2008

Finger ring dosemeters are used at diverse workplaces having ionizing radiation, e.g. in medicine and industry, in order to check whether the effective dose limt values are adhered to. The dosemeters used to measure beta radiation have been subjected to an annual quality control by the PTB for six years now. Since then, all dosimeter models used in Germany have passed these controls.

In Germany, for persons who are occupationally exposed to radiation, monitoring with personal dose equivalent meters is legally prescribed. Besides the whole-body dosimeters which are to be worn on the trunk, also passive extremity dosimeters are used which are often worn around the fingers. Extremity dosimeters are used for beta radiation measurements, especially in medicine. All dosimeters of this type are released and assessed by dosimetry services. PTB is thereby responsible for quality control. Quality control takes place in two stages:

In the first stage, the designs are submitted to a thorough check with regard to their properties before the dosimeter is released for use. In the case of beta dosimeters, this control is carried out according to a directive.

In the second stage, the routine operation is checked yearly at the dosimetry services via so-called "periodic comparison measurements". The dosimeters are thereby exposed by PTB to a well known dose - which we we will call HPTB in the following. Then, the dosimetry services analyse the dosimeters and determine their measured value, HDST, of course without knowing the value of HPTB. As a measure of quality, the quotient HDST/HPTB is used which is 1.0 for an ideal dosimeter. The figure shows the values of these quotients in relation with the dose for all comparison measurements which have been carried out with beta radiation up to now. The lines plotted indicate the admissible limits for this quotient. Due to the requirements of radiation protection, these limits narrow towards high doses.

The condition for passing the yearly comparison measurements is that 90% of all quotients for each design of a service lie within these limits. If this requirement is not met by one dosimeter design for the comparison measurement, a repetition is carried out for this dosimeter. This has never been the case up to now. In summary, one can say that this type of two-stage quality control is particularly efficient.

Source: Physikalisch-Technische Bundesanstalt


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - not rated yet


June 20, 2008 all stories

Comments: 0

not rated yet
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories

  • News from a space phantom
    created Oct 20, 2005 | popularity not rated yet | comments 0
  • Mechanical and nuclear engineers receive award for top-100 technology product of 2009
    created Sep 17, 2009 | popularity not rated yet | comments 0
  • Got ear plugs? You may want to sport them on the subway and other mass transit
    created Jun 19, 2009 | popularity not rated yet | comments 0
  • The Phantom Torso Returns
    created May 28, 2009 | popularity not rated yet | comments 0
  • Needle-size device created to track tumors, radiation dose
    created Apr 08, 2008 | popularity not rated yet | comments 0



  • hide
  • Relevant PhysicsForums posts

Other News

Scientists reveal 'protector' gene behind 50-fold increase in number of bowel tumours

Medicine & Health / Cancer

created 20 minutes ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Cancer Research UK scientists have shown that deleting a single gene can increase the average number of tumours in the bowel by 50-fold, according to research published in PNAS today.


newborn, baby

First anti-seizure drug for newborns to be developed

Medicine & Health / Medications

created 5 minutes ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Researchers at the UCL Institute for Child Health are developing the first anti-seizure drug specifically for newborn babies, with the aim of reducing brain damage.


An end to sleep problems? Researchers discover enzyme behind effects of sleep deprivation

Medicine & Health / Research

created 1hour ago | popularity not rated yet | comments 0

There is hope for those who miss one night too many or whose children keep them up at night. The unwelcome effects of a bad night's sleep - forgetfulness, impaired mental performance - can be dealt with by reducing the concentration ...


Ginkgo biloba doesn’t prevent cardiovascular events but may have potential peripheral artery disease benefits

Medicine & Health / Research

created 1hour ago | popularity not rated yet | comments 0

(PhysOrg.com) -- Ginkgo biloba didn’t prevent cardiovascular death or major events such as heart attack and stroke in people age 75 and older, but the herb may affect peripheral vascular disease, according to research reported ...


Implant-based cancer vaccine is first to eliminate tumors in mice

Implant-based cancer vaccine is first to eliminate tumors in mice

Medicine & Health / Cancer

created 20 hours ago | popularity 4.7 / 5 (22) | comments 4

(PhysOrg.com) -- A cancer vaccine carried into the body on a carefully engineered, fingernail-sized implant is the first to successfully eliminate tumors in mammals, scientists report this week in the journal ...